#Japan #Tokyo #Wellness Tourism #Micro CTC #Cell Cloud

Revolutionizing Wellness Tourism: The Micro CTC Test

As Japan's wellness tourism sector gains momentum, the third International Wellness Tourism Expo (iWT) is set to feature a groundbreaking service from Cell Cloud, a company renowned for its medical innovations. From June 25 to June 27, 2025, at Tokyo Big Sight, the company will showcase its pioneering 'Micro CTC Test', which can detect cancer risks through a simple five-minute blood draw. This marks a significant advancement in personalized health management.

The Micro CTC (Circulating Tumor Cells) test has already garnered multiple awards, including the top prize at the 'The JSSA TOKYO Pitch Award & Meetup Vol.33'. Recognized for its societal contribution and growth potential, this innovative testing method offers a new avenue for travelers seeking health services abroad, thus aligning perfectly with the expanding medical tourism market.

What is Wellness Tourism?

Wellness tourism is defined as travel specifically aimed at enhancing overall well-being. As more individuals seek relaxation and health-focused activities while traveling, the global wellness tourism market continues to expand significantly. The iWT Expo in Tokyo will gather journalists, travel agencies, and wellness enthusiasts to explore this growing industry.

The Emergence of Medical Tourism

Among the various facets of wellness tourism, medical tourism has been drawing considerable attention lately. As international travel resumes, there is an increasing trend of people combining travel with medical services. Notably, previous forecasts predicted that around 400,000 medical tourists from countries like China, Russia, and the U.S. sought healthcare services in Japan before the pandemic.

At this year's expo, Cell Cloud aims to highlight the importance of the Micro CTC Test as an accessible and efficient health check suitable for travelers. Its simplicity—requiring just a quick blood test—makes it an attractive option for those considering medical tourism as part of their trip.

Details About Cell Cloud's Participation

Cell Cloud will have its booth located at East Hall 4-7, Stand 4-18. Throughout the three-day event, multiple informative seminars on the Micro CTC Test's benefits will be conducted. Seminars are scheduled for:

• - 11:00 AM - 11:30 AM
• - 12:30 PM - 1:00 PM
• - 2:00 PM - 2:30 PM
• - 3:30 PM - 4:00 PM

Dr. Tsuyoshi Ohta, a leading authority and Executive Officer at Cell Cloud, will be sharing insights during these sessions. His prestigious background includes serving as an associate professor at Juntendo University and extensive research on cancer treatments.

Exploring the Micro CTC Test

The Micro CTC Test represents a cutting-edge approach in cancer detection. It identifies circulating tumor cells in the blood, providing early warnings for potential health issues. While awareness of this testing procedure remains low in Japan, it has already been widely researched and validated in the West, with over 35,000 related studies published, including FDA approvals.

Utilizing the exclusive CSV (cell surface vimentin) antibody technology, the Micro CTC Test distinguishes between high-grade malignant cells with an impressive specificity of 94.45%. This allows for a safer, more convenient method to assess the risk of various cancers with minimal discomfort.

The test not only enhances the safety and efficiency of cancer screening but also aligns strategically with the growing demand in medical tourism. By promoting the Micro CTC Test, Cell Cloud aims to redefine wellness travel, transforming the way individuals approach their health while exploring new destinations.

Expo Details

• - Event Name: 3rd International Wellness Tourism Expo (iWT)
• - Date: June 25-27, 2025
• - Time: 10:00 AM - 6:00 PM (Closing at 5:00 PM on the last day)
• - Venue: Tokyo Big Sight, East Exhibition Hall 4-7
• - Organizer: RX Japan Co., Ltd.

Transportation Access

Tokyo Big Sight Location: 3-11-1 Ariake, Koto City, Tokyo, 135-0063

• - Nearest Station: Approximately 7 minutes on foot from Kokusai-tenjijo Station (Rinkai Line) and about 3 minutes from Tokyo Big Sight Station (Yurikamome).

In conclusion, the Micro CTC test not only represents a breakthrough in cancer detection but also emphasizes the intertwined future of health and travel. As medical tourism continues to flourish, Cell Cloud's innovative service may pave the way for a healthier and more informed traveler experience.